Racial disparities in the clinical outcomes of triple-negative breast cancer (TNBC) have been well-documented, but the underlying biological mechanisms remain poorly understood. To investigate these disparities, we employed a multi-omic approach integrating imaging mass cytometry and spatial transcriptomics to characterize the tumor microenvironment (TME) in self-identified Black American (BA) and White American (WA) TNBC patients. Our analysis revealed that the TME in BA patients is marked by a network of endothelial cells, macrophages, and mesenchymal-like cells, which correlates with reduced patient survival. In contrast, the WA TNBC microenvironment is enriched in T-cells and neutrophils, indicative of T-cell exhaustion and suppressed immune responses. Ligand-receptor and pathway analyses further demonstrated that BA TNBC tumors exhibit a relatively “immune-cold” profile, while WA TNBC tumors display features of an “inflamed” TME, suggesting the evolution of a unique immunosuppressive mechanism. These findings provide insight into racially distinct tumor-promoting and immunosuppressive microenvironments, which may contribute to the observed differences in clinical outcomes among BA and WA TNBC patients.
9 July 2025 in Cancer Epidemiology, Biomarkers & Prevention
Background: Despite improvements in breast cancer survival, Black versus White women remain at higher risk of death. Exploring reasons behind this disparity is necessary to facilitate interventions. This study evaluated rural–urban residence and/or area deprivation index (ADI) as mediators of the association between race and survival in adults with breast cancer in Alabama. Methods: This retrospective, population-based cohort included 25,195 adult Black or White women with incident breast cancer in Alabama between January 1, 2010, and December 31, 2019. Exposure was self-reported race; mediators were rural–urban status (Rural–Urban Commuting Area codes) and neighborhood deprivation (state-level ADI). The outcome was overall survival from diagnosis to death (any cause) or end of follow-up (December 31, 2021). Results: White women (n = 18,749) were older at diagnosis (62.4 vs. 58.7; P < 0.001), had fewer deaths (21.6% vs. 25.8%; P < 0.001), longer follow-up (70.2 vs. 66.7 months; P < 0.001), lower ADI (4.1 vs. 6.3; P < 0.001), and more rural dwellers (23.2% vs. 18.3%; P < 0.001) compared with Black women (n = 6,446). After full adjustment with rural–urban status and ADI as mediators, there was partial mediation of the race–survival effect [direct effect: hazard ratio = 1.14; 95% confidence interval (CI), 1.06–1.22; indirect effect: hazard ratio = 1.10; 95% CI, 1.07–1.12; and proportion mediated: hazard ratio = 0.45; 95% CI, 0.31–0.64]. These results mirrored the model with ADI as the only mediator, indicating that ADI and not rural–urban status drove the indirect effect. Conclusions: Among Black and White Alabamian women with breast cancer, 45% of the survival disparity is mediated by differences in neighborhood deprivation. Impact: Almost half of the Black–White difference in breast cancer mortality would be eliminated if differences in neighborhood deprivation were improved. See related commentary by Pinheiro and Reeder-Hayes, p. 1683
Androgen receptor (AR)-negative triple-negative breast cancer (TNBC), often termed quadruple-negative breast cancer (QNBC), disproportionately impacts women of African descent, leading to poorer overall survival (OS). MiRNAs regulate the expression of gene drivers involved in critical signaling pathways in TNBC, such as the AR gene, and their expression varies across races and breast cancer subtypes. This study investigates whether differentially expressed miRNAs influence AR transcription, potentially contributing to the observed disparities between African American (AA) and European American (EA) QNBC patients. Race-annotated TNBC samples (n = 129) were analyzed for AR expression status and revealed the prevalence of QNBC in AA patients compared to EA (76.6% vs. 57.7%) and a significant association of AR loss with poor survival among AAs. The Cancer Genome Atlas (TCGA) RNA-seq data showed that AAs with TNBC (n = 32) had lower AR mRNA levels than EAs (n = 67). Among TCGA patients in the AR-low group, AAs had significantly poorer OS than EAs. In our cohort, 46 miRNAs exhibited differential expression between AAs and EAs with QNBC. Ten of these miRNAs (miR-1185-5p, miR-1305, miR-3161, miR-3690, miR-494-3p, miR-509-3-5p, miR-619-3p, miR-628-3p, miR-873-5p, and miR-877-5p) were predicted to target the AR gene/signaling. The loss of AR expression is linked to poorer prognoses in AA women. The understanding of the specific miRNAs involved and their regulatory mechanisms on AR expression could provide valuable insights into why AA women are more prone to QNBC.